Trial ID or NCT#

NCT02465515

Status

RECRUITING

Purpose

Albiglutide is an analogue of glucagon-like peptide-1 (GLP-1), used to treat type 2 diabetes.This study will test whether albiglutide affects the occurrence of major cardiovascular events such as heart attacks or strokes and other important medical outcomes in persons with type 2 diabetes, when used alone or added to other diabetes treatments.

Investigator(s)

Marilyn Tan, MD

Contact us to find out if this trial is right for you.

CONTACT

Stephanie Middleton
(650) 497-5532